Stocks Overview

LAST PRICE
28.1900
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
28.2000/ 15
Ask / Lots
28.5800/ 1
Open / Previous Close
--- / 28.1900
Day Range
---
52 Week Range
Low 25.2000
High 31.6550
Volume
159
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 27.65
Time	Volume	RPRX
09:32 ET	15035	27.6
09:34 ET	1653	27.61
09:36 ET	3566	27.56
09:38 ET	1387	27.66
09:39 ET	2049	27.68
09:41 ET	3962	27.765
09:43 ET	3358	27.78
09:45 ET	3435	27.785
09:48 ET	4142	27.79
09:50 ET	2980	27.8
09:52 ET	10105	27.815
09:54 ET	2480	27.775
09:56 ET	3040	27.803
09:57 ET	2997	27.78
09:59 ET	5131	27.8
10:01 ET	1800	27.915
10:03 ET	2382	27.83
10:06 ET	6625	27.8
10:08 ET	2604	27.77
10:10 ET	13909	27.75
10:12 ET	3186	27.74
10:14 ET	2500	27.78
10:15 ET	4995	27.765
10:17 ET	7869	27.795
10:19 ET	3686	27.76
10:21 ET	4116	27.755
10:24 ET	1338	27.755
10:26 ET	5703	27.7557
10:28 ET	4927	27.75
10:30 ET	3035	27.745
10:32 ET	800	27.75
10:33 ET	5153	27.8
10:35 ET	6711	27.82
10:37 ET	2721	27.795
10:39 ET	7821	27.805
10:42 ET	1350	27.805
10:44 ET	4442	27.79
10:46 ET	4209	27.8
10:48 ET	7238	27.825
10:50 ET	3307	27.855
10:51 ET	4369	27.84
10:53 ET	6201	27.875
10:55 ET	4381	27.855
10:57 ET	8009	27.805
11:00 ET	7116	27.79
11:02 ET	2627	27.785
11:04 ET	7859	27.8
11:06 ET	7209	27.775
11:08 ET	6662	27.775
11:09 ET	1200	27.775
11:11 ET	6538	27.765
11:13 ET	4035	27.775
11:15 ET	2389	27.765
11:18 ET	3000	27.775
11:20 ET	3271	27.79
11:22 ET	700	27.785
11:24 ET	6426	27.795
11:26 ET	2637	27.805
11:27 ET	4971	27.81
11:29 ET	1344	27.805
11:31 ET	12559	27.84
11:33 ET	3361	27.815
11:36 ET	4859	27.855
11:38 ET	7588	27.815
11:40 ET	2577	27.84
11:42 ET	2417	27.86
11:44 ET	3656	27.85
11:45 ET	1049	27.85
11:47 ET	5379	27.88
11:49 ET	6060	27.875
11:51 ET	4616	27.85
11:54 ET	5054	27.875
11:56 ET	2000	27.875
11:58 ET	930	27.87
12:00 ET	1400	27.885
12:02 ET	6873	27.885
12:03 ET	3650	27.875
12:05 ET	2469	27.875
12:07 ET	4114	27.875
12:09 ET	1099	27.885
12:12 ET	11822	27.885
12:14 ET	2582	27.88
12:16 ET	4169	27.88
12:18 ET	4270	27.875
12:20 ET	13024	27.885
12:21 ET	4061	27.8999
12:23 ET	417	27.9
12:25 ET	5758	27.915
12:27 ET	5821	27.92
12:30 ET	1877	27.91
12:32 ET	4041	27.915
12:34 ET	3221	27.925
12:36 ET	1933	27.93
12:38 ET	600	27.94
12:39 ET	100	27.94
12:41 ET	1692	27.945
12:43 ET	1106	27.945
12:45 ET	300	27.9497
12:48 ET	7420	27.965
12:50 ET	100	27.965
12:52 ET	527	27.97
12:54 ET	4138	27.97
12:56 ET	1680	27.985
12:57 ET	8575	27.975
12:59 ET	3960	27.995
01:01 ET	1066	27.995
01:03 ET	3918	28.015
01:06 ET	6137	28.015
01:08 ET	600	28.01
01:10 ET	1074	28.015
01:12 ET	2364	28.004
01:14 ET	7740	27.985
01:15 ET	100	27.985
01:17 ET	2130	27.985
01:19 ET	1520	27.995
01:21 ET	7507	27.994
01:24 ET	2612	27.98
01:26 ET	1268	27.984
01:28 ET	4924	27.985
01:30 ET	7779	28.015
01:32 ET	1026	28.01
01:33 ET	1678	28.015
01:35 ET	5297	28.025
01:37 ET	4493	28.02
01:39 ET	2949	28.025
01:42 ET	1885	28.025
01:44 ET	1903	28.025
01:46 ET	3743	28.055
01:48 ET	7094	28.045
01:50 ET	3748	28.045
01:51 ET	600	28.05
01:53 ET	4467	28.035
01:55 ET	2088	28.02
01:57 ET	740	28.015
02:00 ET	3976	28.035
02:02 ET	8204	28.04
02:04 ET	3877	28.03
02:06 ET	1280	28.035
02:08 ET	1890	28.035
02:09 ET	4486	28.025
02:11 ET	3711	28.005
02:13 ET	4323	28.005
02:15 ET	1355	28.015
02:18 ET	2003	28.025
02:20 ET	2164	28.035
02:22 ET	700	28.035
02:24 ET	6846	28.03
02:26 ET	1129	28.035
02:27 ET	675	28.035
02:29 ET	2658	28.045
02:31 ET	7172	28.04
02:33 ET	4066	28.035
02:36 ET	2346	28.03
02:38 ET	207	28.0248
02:40 ET	2229	28.05
02:42 ET	7190	28.044
02:44 ET	812	28.05
02:45 ET	200	28.045
02:47 ET	2258	28.055
02:49 ET	3472	28.06
02:51 ET	4647	28.08
02:54 ET	1964	28.085
02:56 ET	8898	28.085
02:58 ET	2112	28.085
03:00 ET	1805	28.09
03:02 ET	7414	28.085
03:03 ET	800	28.085
03:05 ET	6082	28.085
03:07 ET	584	28.09
03:09 ET	1917	28.09
03:12 ET	12447	28.09
03:14 ET	6282	28.045
03:16 ET	318	28.045
03:18 ET	1834	28.05
03:20 ET	5044	28.06
03:21 ET	9201	28.035
03:23 ET	600	28.035
03:25 ET	510	28.035
03:27 ET	10002	28.015
03:30 ET	538	28.015
03:32 ET	1877	28.015
03:34 ET	6997	27.995
03:36 ET	2489	28
03:38 ET	5889	28.005
03:39 ET	12367	28.015
03:41 ET	3134	28.015
03:43 ET	5212	28.03
03:45 ET	4700	28.05
03:48 ET	9484	28.07
03:50 ET	11501	28.09
03:52 ET	20324	28.135
03:54 ET	17844	28.165
03:56 ET	33784	28.165
03:57 ET	52520	28.175
03:59 ET	664038	28.19

Data delayed at least 15 minutes.

Sep 20, 2024
- DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones
  7:30AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
- DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
- Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.7B	18.7x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.6B	-13.4x	---
United StatesNDOI Endo Inc	1.9B	0.4x	---
United StatesCTLT Catalent Inc	10.9B	-10.5x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.8B	18.9x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
As of 2024-09-27

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Head of Human Capital: Molly Sawaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.7B
Revenue (TTM)	$2.2B
Shares Outstanding	593.5M
Dividend Yield	2.98%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	08-16-24
Pay Date	09-13-24
Beta	0.46
EPS	$1.50
Book Value	$14.61
P/E Ratio	18.7x
Price/Sales (TTM)	7.5
Price/Cash Flow (TTM)	19.9x
Operating Margin	42.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Sep 20, 2024

DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones

Sep 18, 2024

DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 3, 2024

Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar